Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Agranular CD4+ CD56+ hematodermic neoplasm: a new case report].

M Chamaillard1, M Beylot-Barry, J-F Viallard

  • 1Service de Dermatologie, Hôpital Haut Lévêque, CHU de Bordeaux, avenue de Magellan, 33600 Pessac.

Annales De Dermatologie Et De Venereologie
|February 5, 2005
PubMed
Summary

Agranular CD4+ CD56+ hematodermic neoplasm, a rare cancer of plasmacytoid dendritic cells, presents unique skin and blood characteristics. This distinct entity has a poor prognosis despite various treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Management of hypogammaglobulinemia].

La Revue de medecine interne·2023
Same author

Clinical features associated with the invasive component in lentigo maligna of the head and neck: A retrospective study of 175 cases.

Annales de dermatologie et de venereologie·2022
Same author

[HHV-8 Related immunological and hematological diseases].

La Revue de medecine interne·2021
Same author

Fasciitis secondary to systemic necrotizing vasculitis.

QJM : monthly journal of the Association of Physicians·2021
Same author

Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects.

Blood·2021
Same author

Clinicopathologic analysis of trichoblastoma and comparison with nodular basal cell carcinoma.

Annales de dermatologie et de venereologie·2021

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Agranular CD4+ CD56+ hematodermic neoplasm is a rare hematologic malignancy.
  • This neoplasm is now understood to originate from plasmacytoid dendritic cells.

Observation:

  • An 83-year-old patient presented with purple skin lesions infiltrating the dermis.
  • Biopsy revealed malignant cells (CD4+, CD56+, CD43+) with dermal infiltration, but no bone marrow or blood involvement.
  • The patient achieved remission with chemotherapy but relapsed four months later.

Findings:

  • Agranular CD4+ CD56+ hematodermic neoplasm is distinct from cutaneous lymphomas.
  • Plasmacytoid monocytes expressing CD123 (IL-3 receptor) are identified as malignant precursors.
  • The disease exhibits skin tropism, potential bone marrow involvement, and a poor prognosis.

Related Experiment Videos

Implications:

  • This neoplasm represents a distinct clinicopathologic entity.
  • Current treatments show limited efficacy, highlighting the need for novel therapeutic strategies.
  • Targeting CD123 with antibody-based therapies may offer a promising treatment avenue.